Ana Paula da Costa Marques

Ana Paula da Costa Marques

Auto-generated profile, based on publicly available information

Ana Paula da Costa Marques

Universidade Federal de Mato Grosso do Sul, Brasil

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
LFLarissa Rodrigues Fabris
Larissa Rodrigues Fabris
ÚAÚrsulla Vilella Andrade
Úrsulla Vilella Andrade
ASAline Ferreira Dos Santos
Aline Ferreira Dos Santos
AMAna Paula da Costa Marques
Ana Paula da Costa Marques
SOSandra M.V.L. DE OLIVEIRA
Sandra M.V.L. DE OLIVEIRA
APAnamaria Mello Miranda Paniago
Anamaria Mello Miranda Paniago
With the objective to evaluate the behavior of paracoccidioidomycosis in the last three decades, clinical and epidemiological data of 595 patients admitted to clinical services of the Federal University of Mato Grosso do Sul from 1980 to 2009 were investigated. Gender, age distribution, clinical form, comorbidity with tuberculosis or AIDS, and mortality were compared by decades of clinical admission. It was shown that during the three decades there was a decrease in women percentage, and the same manner occurred a reduction in participants in the age group of 20 to 39 years. Moreover, the acute/subacute forms have been diminished in the period. These fluctuations are closely related and can be simultaneously analyzed. Increased AIDS co-infection prevalence from the first to the second decade was also revealed, coinciding with the appearance of the retroviral epidemic and stabilizing during the third decade. No change in the tuberculosis co-infection rate was observed (overall = 6.9%). It reinforces the importance of this co-morbidity. The overall mortality rate remained steady at 6.7%, not varying significantly from one decade to another. The persistent mortality rate calls attention to the importance of this neglected disease.

1 January 2019 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
UAUrsulla Vilella Andrade
Ursulla Vilella Andrade
SOSandra M.V.L. DE OLIVEIRA
Sandra M.V.L. DE OLIVEIRA
MCMarilene Rodrigues Chang
Marilene Rodrigues Chang
EPEdy Firmina Pereira
Edy Firmina Pereira
AMAna Paula da Costa Marques
Ana Paula da Costa Marques
APAnamaria Mello Miranda Paniago
Anamaria Mello Miranda Paniago
Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to assess their compliance to treatment. In order to be considered compliant, patients needed to present two established criteria: (1) receive medicines from the pharmacy, and (2) achieve a self-reported utilization of at least 80% of the dispensed antifungal compounds prescribed since their previous appointment. Results: Most patients were male (95.7%), had the chronic form of the disease (94.2%), and were treated with cotrimoxazole (86.2%). Only 44.6% of patients were treatment compliant. The highest loss to follow-up was observed in the first 4 months of treatment (p < 0.02). Treatment compliance was higher for patients with than for those without pulmonary involvement (OR: 2.986; 95%CI 1.351-6.599), and higher for patients with than without tuberculosis as co-morbidity (OR: 2.763; 95%CI 1.004-7.604). Conclusions: Compliance to paracoccidioidomycosis treatment was low, and the period with the highest loss to follow-up corresponds to the first four months. Pulmonary paracoccidioidal involvement or tuberculosis comorbidity predicts a higher compliance to paracoccidioidomycosis therapy.


1 October 2004 in Neotropical Entomology
Verified
Journal Article
Open access
PDF file
AMAna P.C. Marques
Ana P.C. Marques
RARosaly Ale-Rocha
Rosaly Ale-Rocha
BRBeatriz Ronchi-Teles
Beatriz Ronchi-Teles

1 January 2026 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
AMAna Paula da Costa Marques
Ana Paula da Costa Marques
VGVanessa Terezinha Gubert
Vanessa Terezinha Gubert
ADAdriano da Costa Dias
Adriano da Costa Dias
AGAntonio Luiz Dal Bello Gasparoto
Antonio Luiz Dal Bello Gasparoto
LSLiara Ferreira dos Santos
Liara Ferreira dos Santos
SOSandra M.V.L. DE OLIVEIRA
Sandra M.V.L. DE OLIVEIRA
Objective: To identify strategies to address vaccine hesitancy. Methods: A search was conducted in Medline, Embase, MedNar, Cochrane Library, Virtual Health Library (VHL), Epistemonikos, Health Systems Evidence, and CINAHL (EBSCO) between June 2024 and February 2025. The selected studies were imported into the Zotero application and subsequently into the Eppi-Reviewer application. Systematic reviews were included, with no restrictions on publication period or language, that address strategies to reduce vaccine hesitancy in an urban Brazilian setting and include adults aged 18 years and older and pregnant women. The synthesis of the results was conducted narratively. Methodological quality was assessed using the A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR 2) and the PROGnosis RESearch Strategy (PROGRESS) framework to analyze equity in vaccination strategies. Results: A total of 1,376 articles were identified, of which 48 systematic reviews were included. The evidence indicated that the strategy to address vaccine hesitancy comprises five actions: strengthening communication for different population groups; implementing continuing education programs for healthcare professionals; expanding population access to vaccines; improving responses to misinformation about vaccines; and integrating vaccination strategies for pregnant women. Conclusion: Effective addressing of vaccine hesitancy requires combined strategies and highlights the need for investments in infrastructure to expand access to vaccines, continuing education processes for healthcare professionals, communication with the population, and innovation in communication approaches and intersectoral coordination.

23 June 2017 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
AMAna Paula C. Marques
Ana Paula C. Marques
SOSandra Maria V. L. Oliveira
Sandra Maria V. L. Oliveira
GRGrazielli R. Rezende
Grazielli R. Rezende
DMDayane A. Melo
Dayane A. Melo
SFSonia M. Fernandes-Fitts
Sonia M. Fernandes-Fitts
APAnamaria Mello Miranda Paniago
Anamaria Mello Miranda Paniago